T. R. Browne

748 total citations
21 papers, 603 citations indexed

About

T. R. Browne is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, T. R. Browne has authored 21 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 11 papers in Pediatrics, Perinatology and Child Health and 4 papers in Molecular Biology. Recurrent topics in T. R. Browne's work include Epilepsy research and treatment (12 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Drug Transport and Resistance Mechanisms (4 papers). T. R. Browne is often cited by papers focused on Epilepsy research and treatment (12 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Drug Transport and Resistance Mechanisms (4 papers). T. R. Browne collaborates with scholars based in United States, Belgium and Mexico. T. R. Browne's co-authors include G. Szabó, J. K. Penry, R. H. Mattson, B. J. Wilder, K. M. SHERRY, Dustin Smith, Elinor Ben‐Menachem, Michael J. Napoliello, Barbara Evans and Ilo E. Leppik and has published in prestigious journals such as Neurology, Clinical Chemistry and British Journal of Clinical Pharmacology.

In The Last Decade

T. R. Browne

20 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. R. Browne United States 15 384 363 188 80 71 21 603
M.J. Brodie United Kingdom 17 425 1.1× 410 1.1× 206 1.1× 56 0.7× 38 0.5× 43 770
Assa Mayersdorf United States 8 914 2.4× 790 2.2× 289 1.5× 84 1.1× 79 1.1× 11 1.1k
Gerard Forrest United Kingdom 17 647 1.7× 549 1.5× 344 1.8× 123 1.5× 41 0.6× 26 948
J. Hardenberg Sweden 7 309 0.8× 208 0.6× 240 1.3× 45 0.6× 52 0.7× 11 458
Philip N. Patsalos United Kingdom 8 435 1.1× 384 1.1× 191 1.0× 92 1.1× 12 0.2× 8 614
Martin J. Brodie United Kingdom 12 730 1.9× 593 1.6× 421 2.2× 122 1.5× 22 0.3× 12 924
A. Rosenberg United States 12 485 1.3× 426 1.2× 227 1.2× 96 1.2× 29 0.4× 13 658
D. J. Easter United Kingdom 9 300 0.8× 313 0.9× 57 0.3× 47 0.6× 33 0.5× 11 454
J. C. Van Meter United States 9 243 0.6× 237 0.7× 81 0.4× 36 0.5× 43 0.6× 14 392
W. C. Yuen United Kingdom 11 1.1k 2.9× 1.1k 3.1× 295 1.6× 281 3.5× 32 0.5× 12 1.3k

Countries citing papers authored by T. R. Browne

Since Specialization
Citations

This map shows the geographic impact of T. R. Browne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. R. Browne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. R. Browne more than expected).

Fields of papers citing papers by T. R. Browne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. R. Browne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. R. Browne. The network helps show where T. R. Browne may publish in the future.

Co-authorship network of co-authors of T. R. Browne

This figure shows the co-authorship network connecting the top 25 collaborators of T. R. Browne. A scholar is included among the top collaborators of T. R. Browne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. R. Browne. T. R. Browne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durso, Raymon, James Evans, G. Szabó, et al.. (2000). Variable Absorption of Carbidopa Affects Both Peripheral and Central Levodopa Metabolism. The Journal of Clinical Pharmacology. 40(8). 854–860. 25 indexed citations
2.
Browne, T. R., et al.. (2000). Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New Technique. The Journal of Clinical Pharmacology. 40(6). 590–595. 46 indexed citations
5.
Browne, T. R., G. Szabó, Gerald E. Schumacher, et al.. (1992). Bioavailability Studies of Drugs with Nonlinear Pharmacokinetics: I. Tracer Dose AUC Varies Directly with Serum Concentration. The Journal of Clinical Pharmacology. 32(12). 1141–1145. 4 indexed citations
6.
Browne, T. R., et al.. (1992). Clinical Therapeutic Conference. The Journal of Clinical Pharmacology. 32(6). 511–519. 1 indexed citations
7.
Browne, T. R. & G. Szabó. (1991). New pharmacokinetic methods for the study of antiepileptic medications of the 1990s.. PubMed. 32 Suppl 5. S66–73. 4 indexed citations
8.
Browne, T. R., R. H. Mattson, J. K. Penry, et al.. (1991). Multicenter long‐term safety and efficacy study of vigabatrin for refractory complex partial seizures. Neurology. 41(3). 363–363. 52 indexed citations
9.
Browne, T. R.. (1990). The pharmacokinetics of agents used to treat status epilepticus.. PubMed. 40(5 Suppl 2). 28–32. 33 indexed citations
10.
Nuwer, Marc R., T. R. Browne, W. E. Dodson, et al.. (1990). Generic substitutions for antiepileptic drugs. Neurology. 40(11). 1647–1647. 56 indexed citations
11.
Browne, T. R., et al.. (1989). A multicentre study of vigabatrin for drug‐resistant epilepsy.. British Journal of Clinical Pharmacology. 27(S1). 95S–100S. 57 indexed citations
12.
Browne, T. R., et al.. (1988). Phenobarbital does not alter phenytoin steady‐state serum concentration or pharmacokinetics. Neurology. 38(4). 639–639. 17 indexed citations
13.
Mikati, Mohamad A., et al.. (1988). Improved high-performance liquid chromatographic assay of antipyrine, hydroxymethylantipyrine, 4-hydroxyantipyrine and norantipyrine in urine. Journal of Chromatography B Biomedical Sciences and Applications. 433. 305–311. 15 indexed citations
14.
Browne, T. R., G. Szabó, James Evans, et al.. (1988). Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance. Neurology. 38(7). 1146–1146. 27 indexed citations
15.
Browne, T. R., R. H. Mattson, J. K. Penry, et al.. (1987). Vigabatrin for refractory complex partial seizures. Neurology. 37(2). 184–184. 144 indexed citations
16.
Browne, T. R., et al.. (1983). Clinical and EEG Estimates of Absence Seizure Frequency. Archives of Neurology. 40(8). 469–472. 28 indexed citations
18.
Biller, J. E., et al.. (1982). Simultaneous determination of phenobarbital andp-hydroxyphenobarbital and their stable isotope labeled analogs by gas chromatography mass spectrometry. Journal of Mass Spectrometry. 9(5). 201–207. 16 indexed citations
19.
Browne, T. R.. (1978). Drug therapy of status epilepticus.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 69(7). 199–207. 8 indexed citations
20.
Browne, T. R.. (1976). Benzodiazepine Anticonvulsant-Reply. Archives of Neurology. 33(10). 731–731. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026